Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

NiGen BioTech's™ "The HCG Solution" Flying Off the Shelf at Walmart After Dr. Oz Show


News provided by

NiGen BioTech

Feb 21, 2013, 03:07 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, Feb. 21, 2013 /PRNewswire/ -- Dr. Oz is always at the forefront when it comes to research breakthroughs, so it's no surprise that when he when he featured HCG diets on his show recently, HCG diet products once again became an overnight topic of conversation. Dr. Oz told his audience that while he'd done a feature on HCG diets last year, he'd decided to revisit the topic after some brand new research became available which showed people on an HCG diet lost an average of 13 pounds, 11 of which was fat.

"We were very excited to hear that Dr. Oz had agreed to do another segment on HCG diets, because thousands upon thousands of people swear by them," says Chantelle Daines, spokesperson for NiGen BioTech™, makers of The HCG Solution™, which has been selling like hotcakes at Walmart, Rite Aid, local GNC retailers, and online at www.MyHCGSolution.com (don't try Walgreens or CVS… they don't have it). "Dr. Oz made it very clear that HCG diets are among the most controversial in the industry, yet two of the guest doctors on his show offer them as weight-loss options to their patients, and members of the audience spoke about the success they've had using them."

HCG diets typically involve prescription HCG injections that are designed to help decrease a person's appetite and help them stick to a very low calorie diet (VLCD)… patients are allowed only 500 calories per day. And some claim remarkable results, losing as much as 100 pounds in only a short time. However, Dr. Oz spoke out against the dangers of these VLCDs, cautioning his audience members against following any weight-loss program of less than 1200 calories per day without being under the care of a professional. He also pointed out numerous times that he was talking about the injectable form of HCG. Many companies offer liquid drops that they claim contain minute amounts of the intact HCG hormone, such as products labeled as "homeopathics," and Dr. Oz clearly stated that these HCG drops don't work.

Dr. Amy Heaton, scientific consultant for NiGen BioTech, agrees: "When taken orally, the HCG hormone would be broken down and would never reach the bloodstream intact. That's why we formulated our branded HCG Solution to contain the full spectrum of human chorionic gonadotropin amino acid isolates derived from certified grade raw materials (the very purest materials available), combined with a proprietary extract that's been proven in two clinical trials to reduce the percentage of body fat."

"We are happy to see that the results of the HCG study announced on the Dr. Oz Show in many ways mimic the studies conducted on the key extract in our branded HCG Solution," says Ms. Daines. "The key extract was proven to cause a significant loss in body fat (an average of 14.6%), so study subjects lost not just body weight, but unsightly, unhealthy body fat."

Unlike the HCG drops condemned by Dr. Oz, the fat-burning component of The HCG Solution has been clinically proven. Two randomized, double-blind, placebo-controlled, human clinical trials have been published in the literature regarding the weight-loss benefits of the key extract. The first study, published in 2007,(J. E. Oben, et al., 2007) involved individuals of both sexes who were classified as obese (BMI>30 kg/m2). The volunteers received two daily doses in the form of capsules of either the key extract found in The HCG Solution (35 volunteers) or a placebo (33 volunteers) for 6 weeks, and each group consumed 2100 kilocalories/day. The capsules were identical in shape, color, and appearance, and neither the participants nor the researchers were informed as to which capsule each volunteer received. The volunteers' weights were measured after 12 hours of fasting using a Tanita™ scale at baseline and at the 6-week duration of the study.

Results show that after only six weeks of supplementation, The HCG Solution key extract led to a significant weight reduction compared to placebo in the volunteers, which averaged 10.6 lbs compared to baseline. In contrast, the placebo did not yield any significant weight change despite both groups having consumed the same 2100 kilocalorie/day diet. These exciting results enticed investigators to carry out yet another clinical trial to further investigate the weight and fat loss properties of this powerful extract.

In this second randomized, double-blind, placebo-controlled study, published in 2008,(J. E. Oben, et al., 2008) 48 obese and overweight subjects were randomly divided into two equal groups (n=24). No major changes in diet or exercise were suggested to the volunteers. The groups received either the same key extract found in The HCG Solution or a placebo twice daily before meals with 8-10 ounces of water. The capsules were identical in shape, color, and appearance, and neither the participants nor the researchers knew which treatment was administered. During the 10-week study period, subjects were evaluated for body weight, percent body fat, and waist circumference. Body weight and percent body fat were measured using a Tanita™ BC-418 Segmental Body Composition Analyzer/Scale that uses a bio-electrical impedance method for body composition analysis. Waist circumference was measured by soft, non-stretchable plastic tape on the narrowest and the widest parts of the trunk, and the values were averaged.

Of important note, some of the waist circumference values from the original publication (J. E. Oben, et al., 2008) raised questions. Indeed, it was verified by the study author J. Oben that a different technician had carried out select waist measurements that were likely taken at a point lower than the navel, as had been the case for the prior measurements from the previous technician. NiGen BioTech therefore acquired the raw data from the study and excluded measurements from the study volunteers that were conducted by this alternative technician. This led to the removal of one volunteer's data from the placebo group and removal of 6 volunteers' data from The HCG Solution extract group.

After 8 weeks of treatment, the group taking the same key extract found in The HCG Solution had lost a significant 16.3 pounds compared to baseline (p<0.05), which increased to 19.4 pounds by week 10 (p<0.01). These results were also significant compared to placebo. In contrast, no weight changes were significant for the placebo group for the duration of the study.

So if you're interested in trying it, don't settle for substitutes or look-alikes. Be sure that any liquid HCG drops you buy are branded with the trade name The HCG Solution and manufactured by NiGen BioTech. Where can you find it? Don't look for it at Walgreens or CVS... they don't have it. Your best bets are Walmart, Rite Aid, and your local GNC, or direct from the manufacturer at www.MyHCGSolution.com or 1-800-310-8589.

PS: If you're going to order online, use promo code HCG20 and get free shipping*.

*Free standard shipping in the continental U.S. only.
All trademarks are the property of their individual owners.

SOURCE NiGen BioTech

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.